Discussion This is a case report of disseminated vaccine (Oka) strain VZV infection resulting
in multiorgan failure and death, following receipt of the live attenuated herpes zoster virus …

In 2016, the live attenuated zoster vaccine (Zostavax, Merck and Co, USA) was introduced
into the Australian National Immunisation Program for people aged 70 years who are not …

Live attenuated varicella vaccine is recommended for healthy individuals who are
susceptible to varicella. Although the vaccine is safe, effective, and used worldwide, serious …

Herpes zoster (HZ) is a common contagious dermatological condition that results from
reactivation of varicella-zoster virus (VZV), which currently could be prevented by …

BACKGROUND: Prior clinical studies of zoster vaccine enrolled subjects without a history of
herpes zoster (HZ), so there are limited data on safety and immunogenicity in vaccinees with …

OBJECTIVE: To evaluate immunogenicity and tolerability of a live attenuated zoster vaccine
in varicella-zoster virus (VZV) seronegative or low-seropositive adults≥ 30 years of age …

Objectives To investigate the safety of live attenuated varicella zoster vaccination when
administered to immunosuppressed individuals. Design Prospective observational cohort …

Herpes zoster, or shingles, results from the reactivation of latent varicella-zoster virus (VZV)
in the dorsal-root or cranial-nerve ganglia, usually decades after primary infection. Herpes …

Abstract Background In Japan, freeze-dried live attenuated varicella-zoster vaccine is
available for adults aged≥ 50 years to prevent herpes zoster. However, limited evidence …

A 64-year-old immunocompetent man developed a widespread pruritic and vesicular rash 2
weeks after receiving the zoster vaccine (Zostavax). He had fever, bandaemia with normal …